Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain)
Home
Publications
Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain)
Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain)
Authors:
EN
E Navas
E Navas
LS
L Salleras
L Salleras
RG
R Gisbert
R Gisbert
AD
A Dominguez
A Dominguez
ET
E Timoner
E Timoner
DI
D Ibanez
D Ibanez
AP
A Prat
A Prat
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
18 March 2005
journal article
research article
Published by
Elsevier
in
Vaccine
Vol. 23
(17-18)
,
2342-2348
DOI:
10.1016/j.vaccine.2005.01.018
PMID:
15755625
Abstract
No abstract available
Keywords
COSTS AND BENEFITS
COST BENEFIT ANALYSIS
INCIDENCE RATE
COST EFFECTIVENESS
NET PRESENT VALUE
Cited
Cited by 20 articles
Scroll to top